Glenmark Pharmaceuticals Ltd. Renews CRM Contract with Data3s in Two European Countries
Data3s, a leading provider of customer relationship management solutions for the life sciences, today announced that the Czech and Slovak offices of Glenmark Pharmaceuticals Ltd. have renewed their contract for CRM and related services for another three years.
Prague, Czech Republic, November 30, 2011 --(PR.com)-- Data3s, a leading provider of customer relationship management solutions for the life sciences, today announced that the Czech and Slovak offices of Glenmark Pharmaceuticals Ltd. have renewed their contract for CRM and related services for another three years.
"We renewed our contract because we are extremely satisfied with the quality of Data3s' products and services," said Jiří Havránek, General Manager of Glenmark Czech Republic and Slovakia.
Havránek cited the rapid and ongoing changes in the Czech and Slovak markets as the primary reason for expanding the contract to include even more products and services from Data3s, saying:
"While we are extremely satisfied with the modules we've had so far, we need more tools to help us improve our sales force effectiveness in a new and changing environment. This is why the renewal of the contract represents not just an extension of the previous contract, but an expansion into a whole new set of products and services."
Glenmark's extended contract provides a number of new offerings from Data3s, including an upcoming SaaS CRM solution for mobile devices (eluzzion Mobile) to be launched early next year, as well as extended applications for Clinical Trials, Key Account Management, and a fully-integrated Closed Loop Marketing platform for tablets.
"CRM is critical to our ability to maintain competitiveness in our markets," Havránek added, "and we are confident that Data3s will provide us with the best tools for our markets."
Speaking from Prague, Antonín Lukeš, CEO of Data3s, said, "This contract renewal was symbolically very important to us. Glenmark was among our first customers when we started out, and we greatly appreciate the confidence in our work that Glenmark has shown us. We will absolutely strive to continue to meet and exceed their high expectations."
About Glenmark Pharmaceuticals Ltd.:
Glenmark (GPL) is a research-driven, global, fully integrated pharmaceutical company headquartered at Mumbai, India. We employ over 4100 people across the globe, with branded generic formulation interests in over 95 countries across the world including India, Europe, Brazil, Latin America, Russia/CIS, Africa and Asia.
About eluzzion CRM:
eluzzion CRM is an innovative customer relationship management solution for life science organizations that boasts one of the most complete and user-friendly interfaces in pharma. A preferred solution of global generics companies, eluzzion CRM is the leader in complete front-to-back end CRM, complementing robust campaign management support with advanced sales analytics, expense management and business intelligence tools, as well as integrated e-Learning, clinical trials management, and closed loop marketing platforms.
About Data3s:
Data3s is one of the fastest growing providers of software solutions for life sciences companies, bringing customer relationship management, business intelligence, eLearning, clinical trials management, supply chain information management and ICT consulting solutions to life science organizations world wide. Founded in 2006, Data3s is a privately-owned company headquartered in Prague, with partners and representative offices in Paris, Warsaw, Istanbul, Mumbai, Dubai, Jakarta and Sao Paulo.
For more information, please visit: http://data3s.com/pharma-crm.
###
"We renewed our contract because we are extremely satisfied with the quality of Data3s' products and services," said Jiří Havránek, General Manager of Glenmark Czech Republic and Slovakia.
Havránek cited the rapid and ongoing changes in the Czech and Slovak markets as the primary reason for expanding the contract to include even more products and services from Data3s, saying:
"While we are extremely satisfied with the modules we've had so far, we need more tools to help us improve our sales force effectiveness in a new and changing environment. This is why the renewal of the contract represents not just an extension of the previous contract, but an expansion into a whole new set of products and services."
Glenmark's extended contract provides a number of new offerings from Data3s, including an upcoming SaaS CRM solution for mobile devices (eluzzion Mobile) to be launched early next year, as well as extended applications for Clinical Trials, Key Account Management, and a fully-integrated Closed Loop Marketing platform for tablets.
"CRM is critical to our ability to maintain competitiveness in our markets," Havránek added, "and we are confident that Data3s will provide us with the best tools for our markets."
Speaking from Prague, Antonín Lukeš, CEO of Data3s, said, "This contract renewal was symbolically very important to us. Glenmark was among our first customers when we started out, and we greatly appreciate the confidence in our work that Glenmark has shown us. We will absolutely strive to continue to meet and exceed their high expectations."
About Glenmark Pharmaceuticals Ltd.:
Glenmark (GPL) is a research-driven, global, fully integrated pharmaceutical company headquartered at Mumbai, India. We employ over 4100 people across the globe, with branded generic formulation interests in over 95 countries across the world including India, Europe, Brazil, Latin America, Russia/CIS, Africa and Asia.
About eluzzion CRM:
eluzzion CRM is an innovative customer relationship management solution for life science organizations that boasts one of the most complete and user-friendly interfaces in pharma. A preferred solution of global generics companies, eluzzion CRM is the leader in complete front-to-back end CRM, complementing robust campaign management support with advanced sales analytics, expense management and business intelligence tools, as well as integrated e-Learning, clinical trials management, and closed loop marketing platforms.
About Data3s:
Data3s is one of the fastest growing providers of software solutions for life sciences companies, bringing customer relationship management, business intelligence, eLearning, clinical trials management, supply chain information management and ICT consulting solutions to life science organizations world wide. Founded in 2006, Data3s is a privately-owned company headquartered in Prague, with partners and representative offices in Paris, Warsaw, Istanbul, Mumbai, Dubai, Jakarta and Sao Paulo.
For more information, please visit: http://data3s.com/pharma-crm.
###
Contact
Data System Solutions s.r.o.
Joshua Mensch
+420 241771214
http://data3s.com
Joshua Mensch
+420 241771214
http://data3s.com
Contact
Categories